Literature DB >> 25721338

Expression of DJ-1 and mTOR in eutopic and ectopic endometria of patients with endometriosis and adenomyosis.

Jiubai Guo1, Jumei Gao, Xiaohong Yu, Hailian Luo, Xiasi Xiong, Ouping Huang.   

Abstract

OBJECTIVE: Endometrial cells may aberrantly express molecules involved in invasion and migration, leading to endometriosis. The aim of this study was to investigate the expression of DJ-1 and phosphorylated mammalian target of rapamycin (p-mTOR) in ectopic and eutopic endometria of endometriosis and adenomyosis.
METHODS: Endometrial specimens were obtained from healthy non-menopausal women (n = 17) or patients with ovarian endometriotic cysts (n = 48) or adenomyosis (n = 30) during January 2011 to June 2012. The expressions of DJ-1 and p-mTOR were evaluated by immunohistochemistry and western blotting methods.
RESULTS: The expressions of DJ-1 and p-mTOR were significantly higher in the ectopic endometria than those in the eutopic endometria of endometriosis and adenomyosis patients or normal endometria (FDR < 0.05). DJ-1 expression was positively correlated with the p-mTOR expression no matter at endometriosis (r = 0.736, FDR < 0.001) or adenomyosis (r = 0.809, FDR < 0.001).
CONCLUSION: DJ-1 protein may be involved in endometrial cells proliferation, migration and angiogenesis by modulating the PI3K/Akt/p-mTOR signaling pathway, which provides an underlying theoretical target for endometriosis and adenomyosis.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25721338     DOI: 10.1159/000365569

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.

Authors:  Marissa J Harmsen; Caroline F C Wong; Velja Mijatovic; Arjan W Griffioen; Freek Groenman; Wouter J K Hehenkamp; Judith A F Huirne
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

Review 2.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

Review 3.  Role of mTOR Signaling in Female Reproduction.

Authors:  Zaixin Guo; Qi Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

4.  Anti-Inflammatory Activity of Sanjie Zhentong Capsule Assessed By Network Pharmacology Analysis of Adenomyosis Treatment.

Authors:  Li Du; De-Hui Du; Biao Chen; Yue Ding; Tong Zhang; Wei Xiao
Journal:  Drug Des Devel Ther       Date:  2020-02-20       Impact factor: 4.162

Review 5.  The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.

Authors:  Tatiana S Driva; Christoph Schatz; Monika Sobočan; Johannes Haybaeck
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

6.  Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.

Authors:  Karly-Rai Rogers-Broadway; Juhi Kumar; Cristina Sisu; Gurleen Wander; Emily Mazey; Jeyarooban Jeyaneethi; George Pados; Dimitris Tsolakidis; Eleftherios Klonos; Thomas Grunt; Marcia Hall; Jayanta Chatterjee; Emmanouil Karteris
Journal:  Int J Mol Med       Date:  2018-10-31       Impact factor: 4.101

7.  Inhibitory Effects of 6,8-Diprenylorobol on Endometriosis Progression in Humans by Disrupting Calcium Homeostasis and Mitochondrial Function.

Authors:  Jisoo Song; Gwonhwa Song; Sunwoo Park; Whasun Lim
Journal:  Antioxidants (Basel)       Date:  2022-01-17

Review 8.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.